Nymox Pharmaceutical Corp. buy krebskrebs
Start price
28.06.21
/
50%
€1.38
Target price
28.06.22
€2.50
Performance (%)
-71.16%
End price
29.06.22
€0.40
Summary
This prediction ended on 29.06.22 with a price of €0.40. The BUY prediction by krebskrebs for Nymox Pharmaceutical Corp. performed very badly with a performance of -71.16%. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Nymox Pharmaceutical Corp. | - | - | - | - |
iShares Core DAX® | -1.958% | 4.037% | 23.702% | 22.534% |
iShares Nasdaq 100 | 0.272% | 8.670% | 28.181% | 41.859% |
iShares Nikkei 225® | 0.377% | 7.232% | 21.118% | 9.739% |
iShares S&P 500 | 0.370% | 6.511% | 29.221% | 41.850% |
Comments by krebskrebs for this prediction
In the thread Nymox Pharmaceutical Corp. diskutieren
Buy mit Kursziel 2,5
In the thread Trading Nymox Pharmaceutical Corp.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten